We determined the methylation patterns in tumor, tumor-adjacent and tumor-distant tissues from the same breast cancer patients in order to investigate if aberrant promoter methylation levels of ABCB1, ABCC1 and ABCG2 can be used as indicator for detection of field cancerization in breast cancer. Here, ABCG2 is linked to breast carcinoma.